|
US2956926A
(en)
*
|
1958-09-23 |
1960-10-18 |
American Cyanamid Co |
Coated citric acid particles
|
|
NZ196348A
(en)
*
|
1980-03-07 |
1984-08-24 |
Interx Research Corp |
Enhancement of absorption rate of orally administered antibiotics
|
|
JPS57146723A
(en)
*
|
1981-03-06 |
1982-09-10 |
Toyo Jozo Co Ltd |
Pharmaceutical preparation having improved absorption
|
|
US4537772A
(en)
*
|
1984-05-02 |
1985-08-27 |
Merck & Co., Inc. |
Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
|
|
US5789234A
(en)
|
1987-08-14 |
1998-08-04 |
Unigene Laboratories, Inc. |
Expression systems for amidating enzyme
|
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
|
DE69841939D1
(de)
|
1997-04-16 |
2010-11-25 |
Unigene Lab Inc |
Direkte expression von peptiden ins kulturmedium
|
|
WO2001056594A1
(en)
|
2000-02-04 |
2001-08-09 |
Unigene Laboratories, Inc. |
Nasal calcitonin formulations
|
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
|
US7316819B2
(en)
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
CA2445860A1
(en)
*
|
2001-04-30 |
2002-11-07 |
Shire Laboratories Inc. |
Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers
|
|
US8088734B2
(en)
|
2003-01-21 |
2012-01-03 |
Unigene Laboratories Inc. |
Oral delivery of peptides
|
|
US20050215476A1
(en)
*
|
2004-01-21 |
2005-09-29 |
Unigene Laboratories Inc. |
Amidated parathyroid hormone fragments and uses thereof
|
|
US8227241B2
(en)
|
2004-03-12 |
2012-07-24 |
Unigene Laboratories, Inc. |
Bacterial host cell for the direct expression of peptides
|
|
KR20050104152A
(ko)
|
2004-04-28 |
2005-11-02 |
최승호 |
경구용 약물의 흡수를 증진하는 약제학적 조성물
|
|
US20050282756A1
(en)
|
2004-06-18 |
2005-12-22 |
Mehta Nozer M |
Oral delivery of peptide pharmaceutical compositions
|
|
WO2006026592A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Oral administration of poorly absorbed drugs, methods and compositions related thereto
|
|
US7445911B2
(en)
|
2004-11-24 |
2008-11-04 |
Unigene Laboratories Inc. |
Enzymatic reactions in the presence of keto acids
|
|
ES2437068T3
(es)
|
2005-06-24 |
2014-01-08 |
Enteris Biopharma, Inc. |
Líneas celulares para expresar enzima útil en la preparación de productos amidados
|
|
US7449896B2
(en)
*
|
2005-07-29 |
2008-11-11 |
Ixys Corporation |
Current sensor using level shift circuit
|
|
US8093207B2
(en)
|
2005-12-09 |
2012-01-10 |
Unigene Laboratories, Inc. |
Fast-acting oral peptide pharmaceutical products
|
|
AU2006331685A1
(en)
*
|
2005-12-22 |
2007-07-05 |
Wyeth |
Methods of treating gastrointestinal tract infections with tigecycline
|
|
JPWO2007072911A1
(ja)
*
|
2005-12-22 |
2009-06-04 |
アスビオファーマ株式会社 |
塩酸サプロプテリンの生体内吸収性を向上させた製剤
|
|
AR060355A1
(es)
*
|
2007-04-04 |
2008-06-11 |
Kelly Jose Luis |
Aparato para disipar el agua producida por equipos de climatizacion
|
|
US8377863B2
(en)
|
2007-05-29 |
2013-02-19 |
Unigene Laboratories Inc. |
Peptide pharmaceutical for oral delivery
|
|
WO2009061805A1
(en)
*
|
2007-11-05 |
2009-05-14 |
Scolr Pharma, Inc. |
Formulations for enhanced bioavailability of orally administered polar agents
|
|
US20100256060A1
(en)
*
|
2009-04-02 |
2010-10-07 |
Unigene Laboratories Inc. |
Peptide pharmaceuticals for nasal delivery
|
|
US20120071410A1
(en)
|
2010-09-21 |
2012-03-22 |
Unigene Laboratories Inc. |
Calcitonin products and therapies for treating inflammatory or degenerative diseases
|
|
RS56998B1
(sr)
|
2010-12-16 |
2018-05-31 |
Novo Nordisk As |
Čvrste kompozicije koje sadrže agonist glp-1 i so n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline
|
|
CN103764159A
(zh)
*
|
2011-06-14 |
2014-04-30 |
康肽德生物医药技术有限公司 |
芳香族阳离子肽及其用途
|
|
PL2720707T3
(pl)
|
2011-06-15 |
2019-06-28 |
Resother Pharma Aps |
Przeciwzapalne produkty farmaceutyczne
|
|
ES2774962T3
(es)
|
2013-03-05 |
2020-07-23 |
Enteris Biopharma Inc |
Productos farmacéuticos de administración oral
|
|
CN107427469B
(zh)
|
2015-01-12 |
2021-01-26 |
安特里斯生物制药公司 |
固体口服剂型
|